Titan Biotech Limited (TITANBIO.BO)

INR 781.0

(1.07%)

Net Debt Summary of Titan Biotech Limited

Titan Biotech Limited's latest annual net debt in 2023 was 54.62 Million INR , up 49.75% from previous year.
Titan Biotech Limited's latest quarterly net debt in 2023 FY was 54.62 Million INR , up 49.75% from previous quarter.
Titan Biotech Limited reported annual net debt of 36.48 Million INR in 2022, down -26.86% from previous year.
Titan Biotech Limited reported annual net debt of 49.87 Million INR in 2021, down -46.59% from previous year.
Titan Biotech Limited reported quarterly net debt of 40.01 Million INR for 2023 Q2, down 0.0% from previous quarter.
Titan Biotech Limited reported quarterly net debt of 54.62 Million INR for 2023 Q4, down 0.0% from previous quarter.

Annual Net Debt Chart of Titan Biotech Limited (2023 - 2008)

Historical Annual Net Debt of Titan Biotech Limited (2023 - 2008)

Year	Net Debt	Net Debt Growth
2023	54.62 Million INR	49.75%
2022	36.48 Million INR	-26.86%
2021	49.87 Million INR	-46.59%
2020	93.38 Million INR	-57.63%
2019	220.42 Million INR	1.23%
2018	217.74 Million INR	-13.03%
2017	250.37 Million INR	37.01%
2016	182.74 Million INR	105.05%
2015	89.12 Million INR	21.25%
2014	73.5 Million INR	46.4%
2013	50.21 Million INR	212.88%
2012	16.04 Million INR	22.15%
2011	13.13 Million INR	-46.85%
2010	24.71 Million INR	120.39%
2009	11.21 Million INR	149.54%
2008	4.49 Million INR	0.0%

Year	Net Debt	Net Debt Growth
2023 Q3	- INR	-100.0%
2023 Q2	40.01 Million INR	0.0%
2023 Q4	54.62 Million INR	0.0%
2023 FY	54.62 Million INR	49.75%
2023 Q1	- INR	-100.0%
2022 Q4	36.48 Million INR	0.0%
2022 Q3	- INR	-100.0%
2022 Q2	38.64 Million INR	89.05%
2022 Q1	20.43 Million INR	-59.02%
2022 FY	36.48 Million INR	-26.86%
2021 Q2	90.67 Million INR	-17.25%
2021 Q1	109.57 Million INR	17.34%
2021 FY	49.87 Million INR	-46.59%
2021 Q4	49.87 Million INR	-66.69%
2021 Q3	149.76 Million INR	65.17%
2020 Q1	159.97 Million INR	-27.42%
2020 Q3	57.15 Million INR	-51.29%
2020 FY	93.38 Million INR	-57.63%
2020 Q4	93.38 Million INR	63.38%
2020 Q2	117.33 Million INR	-26.65%
2019 Q2	212.92 Million INR	0.0%
2019 FY	220.42 Million INR	1.23%
2019 Q4	220.42 Million INR	0.0%
2018 Q2	235.71 Million INR	0.0%
2018 FY	217.74 Million INR	-13.03%
2018 Q4	217.74 Million INR	0.0%
2017 Q4	250.37 Million INR	0.0%
2017 FY	250.37 Million INR	37.01%
2017 Q2	219.06 Million INR	0.0%
2016 Q2	85.38 Million INR	0.0%
2016 FY	182.74 Million INR	105.05%
2016 Q4	182.74 Million INR	0.0%
2015 Q4	89.12 Million INR	0.0%
2015 Q2	35.12 Million INR	0.0%
2015 FY	89.12 Million INR	21.25%
2014 Q4	73.5 Million INR	0.0%
2014 FY	73.5 Million INR	46.4%
2013 FY	50.21 Million INR	212.88%
2013 Q2	-8.4 Million INR	0.0%
2013 Q4	50.21 Million INR	0.0%
2012 Q4	16.04 Million INR	0.0%
2012 FY	16.04 Million INR	22.15%
2011 FY	13.13 Million INR	-46.85%
2011 Q4	13.13 Million INR	0.0%
2010 FY	24.71 Million INR	120.39%
2010 Q4	24.71 Million INR	0.0%
2009 FY	11.21 Million INR	149.54%
2008 FY	4.49 Million INR	0.0%
2008 Q4	4.49 Million INR	0.0%

Peer Net Debt Comparison of Titan Biotech Limited

Name	Net Debt	Net Debt Difference
Alfavision Overseas (India) Limited	1.35 Billion INR	95.968%
Biocon Limited	140.18 Billion INR	99.961%
Blue Jet Healthcare Limited	-830.93 Million INR	106.574%
Concord Biotech Limited	-372.86 Million INR	114.651%
Dishman Carbogen Amcis Limited	18.99 Billion INR	99.712%
FERMENTA BIOTECH LIMITED	1.1 Billion INR	95.054%
GENOMIC VALLEY BIOTECH LIMITED	-60.73 Thousand INR	90046.323%
Lyka Labs Limited	527.01 Million INR	89.634%
Panacea Biotec Limited	-1.18 Billion INR	104.61%
SAMSRITA LABS LIMITED	21.98 Million INR	-148.43%
Servoteach Industries Limited	5016.00 INR	-1088974.96%
SMS Lifesciences India Limited	992.31 Million INR	94.495%
Supriya Lifescience Limited	-694.68 Million INR	107.864%
Syngene International Limited	-83 Million INR	165.817%
TAKE Solutions Limited	361.37 Million INR	84.883%
Transgene Biotek Limited	139.93 Million INR	60.961%
Vanta Bioscience Limited	607.93 Million INR	91.014%